Zhongshan Jvtech Silicone Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Zhongshan Jvtech Silicone Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include JT. The owner is based in Zhongshan,Guangdong.

Buiding A, Shoul i Industrial Park

Minzhong Town

Zhongshan,Guangdong 528400 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

JT
JT
Registered 2024

Trademark Classifications

Zhongshan Jvtech Silicone Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Zhongshan Jvtech Silicone Technology Co., Ltd. have?

Zhongshan Jvtech Silicone Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Zhongshan Jvtech Silicone Technology Co., Ltd. file in?

Zhongshan Jvtech Silicone Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Zhongshan Jvtech Silicone Technology Co., Ltd.'s most well-known trademarks?

Zhongshan Jvtech Silicone Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as JT. These are among 1 currently registered trademark in the portfolio.

What is Zhongshan Jvtech Silicone Technology Co., Ltd.'s trademark registration success rate?

Zhongshan Jvtech Silicone Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.